Skip to content

Effect of functional foods on Metabolic Syndrome

Effect of nutraceuticals on Metabolic Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8v7qhq
Enrollment
Unknown
Registered
2018-05-22
Start date
2010-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

The study enrollment was completed in four years. A total of 223 individuals responded to the recruitment effort and 154 eligible, were assigned to a six week protocol. Twelve participants have discon
Dietary supplement
B01.650.940.800.575.912.250.822.060
SP6.051.227

Sponsors

Universidade Federal do Estado do Rio de Janeiro
Lead Sponsor
Escola Nacional de Saúde Pública/FioCruz
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Subjects aged 18 or older; carrying Metabolic Syndrome criteria according to the National Cholesterol Education Program Adult Treatment Panel III criteria (NCEP ATPIII 2001); who consented formally to join the study

Exclusion criteria

Exclusion criteria: Those who had diagnostic for thyroid abnormalities; hepatic ou renal failure; under treatment for corticoids; hipolipemiant drugs or low calorie diet on the last three months

Design outcomes

Primary

MeasureTime frame
Higher (20%) remission of Metabolic Syndrome for the intervention group, which was the group that received low calorie diet plus oat bran trough estimative of prevalence index of metabolic syndrome before and after the intervention period;There was a 37% remission of metabolic syndrome for intervention group and 35,2 for control groups

Secondary

MeasureTime frame
Reduction of patients proportion waist circumference with values above 102cm for men and 88cm for women higher than 20% for intervention group than control group;There was a 7,1% reduction of patients with high waist circumference for intervention group and 14,3% for control group (which is a higher reduction for control group);Reduction of patients proportion plasma triglycerides with values above 150mg/dL , higher than 20% for intervention group than control group;There was a 32,3% reduction of patients with hypertrigliceridemia for intervention group and 37,3% for control group (which is a higher reduction for control group);Reduction of patients proportion with hdl cholesterol lower than 40mg/dL for men and 50mg/dL for women, higher than 20% for intervention group than control group;There was a reduction of patients with low hdl cholesterol of 2,1% for intervention group and 6,9% for control group (which is a higher reduction for control group) ;Reduction of patients proportion blood pressure with values above 130 x 85 mmHg, higher than 20% for intervention group than control group;There was a reduction of patients proportion with high blood pressure of 38,4% for intervention group and 37,3% for control group (1,1% higher) ;Reduction of patients proportion hyperglicemia with values above 130 x 85 mmHg, higher than 20% for intervention group than control group;There was a reduction of patients with hyperglicemia of 39,4% for intervention group and 44,7% for control group (which is a higher reduction for control group)

Countries

Brazil

Contacts

Public ContactLeila Leão

Universidade Federal do Estado do Rio de Janeiro

leilaleao@gmail.com55021972741867

Outcome results

None listed

Source: REBEC (via WHO ICTRP)